TELEFLEX INC (TFX) Stock Fundamental Analysis
USA - NYSE:TFX - US8793691069 - Common Stock
126.08 USD
+0.19 (+0.15%)
Overall TFX gets a fundamental rating of 6 out of 10. We evaluated TFX against 191 industry peers in the Health Care Equipment & Supplies industry. While TFX has a great profitability rating, there are some minor concerns on its financial health. TFX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make TFX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year TFX was profitable.
TFX had a positive operating cash flow in the past year.
Each year in the past 5 years TFX has been profitable.
Each year in the past 5 years TFX had a positive operating cash flow.
1.2 Ratios
TFX has a Return On Assets of 2.60%. This is in the better half of the industry: TFX outperforms 76.96% of its industry peers.
With a decent Return On Equity value of 4.52%, TFX is doing good in the industry, outperforming 76.44% of the companies in the same industry.
The Return On Invested Capital of TFX (7.80%) is better than 85.86% of its industry peers.
TFX had an Average Return On Invested Capital over the past 3 years of 7.21%. This is in line with the industry average of 8.46%.
The last Return On Invested Capital (7.80%) for TFX is above the 3 year average (7.21%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.52% | ||
| ROIC | 7.8% |
ROA(3y)3.65%
ROA(5y)4.54%
ROE(3y)6.23%
ROE(5y)8.33%
ROIC(3y)7.21%
ROIC(5y)7.23%
1.3 Margins
TFX's Profit Margin of 6.31% is fine compared to the rest of the industry. TFX outperforms 78.01% of its industry peers.
TFX's Profit Margin has declined in the last couple of years.
TFX's Operating Margin of 19.49% is amongst the best of the industry. TFX outperforms 92.15% of its industry peers.
In the last couple of years the Operating Margin of TFX has remained more or less at the same level.
Looking at the Gross Margin, with a value of 55.59%, TFX is in line with its industry, outperforming 51.31% of the companies in the same industry.
TFX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.49% | ||
| PM (TTM) | 6.31% | ||
| GM | 55.59% |
OM growth 3Y-3.43%
OM growth 5Y0.95%
PM growth 3Y-49.04%
PM growth 5Y-33.65%
GM growth 3Y0.43%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TFX is destroying value.
The number of shares outstanding for TFX has been reduced compared to 1 year ago.
Compared to 5 years ago, TFX has less shares outstanding
Compared to 1 year ago, TFX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.72 indicates that TFX is not a great score, but indicates only limited risk for bankruptcy at the moment.
TFX has a better Altman-Z score (2.72) than 68.06% of its industry peers.
The Debt to FCF ratio of TFX is 4.80, which is a neutral value as it means it would take TFX, 4.80 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.80, TFX belongs to the best of the industry, outperforming 81.15% of the companies in the same industry.
TFX has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
TFX's Debt to Equity ratio of 0.42 is in line compared to the rest of the industry. TFX outperforms 44.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 4.8 | ||
| Altman-Z | 2.72 |
ROIC/WACC1
WACC7.81%
2.3 Liquidity
TFX has a Current Ratio of 2.41. This indicates that TFX is financially healthy and has no problem in meeting its short term obligations.
TFX's Current ratio of 2.41 is in line compared to the rest of the industry. TFX outperforms 48.17% of its industry peers.
TFX has a Quick Ratio of 1.44. This is a normal value and indicates that TFX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TFX (1.44) is worse than 60.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.71% over the past year.
The Earnings Per Share has been growing slightly by 4.67% on average over the past years.
The Revenue has been growing slightly by 1.11% in the past year.
The Revenue has been growing slightly by 3.26% on average over the past years.
EPS 1Y (TTM)2.71%
EPS 3Y1.67%
EPS 5Y4.67%
EPS Q2Q%9.06%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.74%
Revenue growth 5Y3.26%
Sales Q2Q%2.28%
3.2 Future
Based on estimates for the next years, TFX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.54% on average per year.
Based on estimates for the next years, TFX will show a small growth in Revenue. The Revenue will grow by 7.72% on average per year.
EPS Next Y1.3%
EPS Next 2Y3.42%
EPS Next 3Y3.82%
EPS Next 5Y8.54%
Revenue Next Year8.17%
Revenue Next 2Y9.41%
Revenue Next 3Y7.86%
Revenue Next 5Y7.72%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
TFX is valuated reasonably with a Price/Earnings ratio of 8.99.
TFX's Price/Earnings ratio is rather cheap when compared to the industry. TFX is cheaper than 94.24% of the companies in the same industry.
TFX is valuated cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
TFX is valuated reasonably with a Price/Forward Earnings ratio of 8.41.
Based on the Price/Forward Earnings ratio, TFX is valued cheaply inside the industry as 96.86% of the companies are valued more expensively.
TFX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 8.41 |
4.2 Price Multiples
94.24% of the companies in the same industry are more expensive than TFX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, TFX is valued cheaper than 93.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.05 | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TFX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.9
PEG (5Y)1.92
EPS Next 2Y3.42%
EPS Next 3Y3.82%
5. Dividend
5.1 Amount
TFX has a Yearly Dividend Yield of 1.03%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.69, TFX pays a better dividend. On top of this TFX pays more dividend than 94.76% of the companies listed in the same industry.
With a Dividend Yield of 1.03, TFX pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
5.2 History
The dividend of TFX has a limited annual growth rate of 0.04%.
TFX has been paying a dividend for at least 10 years, so it has a reliable track record.
As TFX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.04%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
32.17% of the earnings are spent on dividend by TFX. This is a low number and sustainable payout ratio.
TFX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.17%
EPS Next 2Y3.42%
EPS Next 3Y3.82%
NYSE:TFX (9/16/2025, 3:51:05 PM)
126.08
+0.19 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.15%
Inst Owner Change-5.71%
Ins Owners0.29%
Ins Owner Change3.7%
Market Cap5.57B
Analysts54.29
Price Target142.6 (13.1%)
Short Float %2.14%
Short Ratio1.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
Yearly Dividend1.36
Dividend Growth(5Y)0.04%
DP32.17%
Div Incr Years0
Div Non Decr Years6
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.31%
Min EPS beat(2)-1.22%
Max EPS beat(2)9.84%
EPS beat(4)2
Avg EPS beat(4)2.55%
Min EPS beat(4)-1.22%
Max EPS beat(4)9.84%
EPS beat(8)6
Avg EPS beat(8)3.51%
EPS beat(12)10
Avg EPS beat(12)3.46%
EPS beat(16)14
Avg EPS beat(16)3.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.8%
Max Revenue beat(2)0.22%
Revenue beat(4)1
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.7%
Revenue beat(12)5
Avg Revenue beat(12)-0.44%
Revenue beat(16)7
Avg Revenue beat(16)-0.52%
PT rev (1m)-0.32%
PT rev (3m)-7.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.17%
EPS NY rev (1m)4.8%
EPS NY rev (3m)5.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.92%
Revenue NY rev (1m)6.66%
Revenue NY rev (3m)7.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 8.41 | ||
| P/S | 1.83 | ||
| P/FCF | 14.05 | ||
| P/OCF | 10.83 | ||
| P/B | 1.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.32 |
EPS(TTM)14.02
EY11.12%
EPS(NY)14.98
Fwd EY11.88%
FCF(TTM)8.97
FCFY7.12%
OCF(TTM)11.64
OCFY9.23%
SpS68.82
BVpS96.01
TBVpS-14.38
PEG (NY)6.9
PEG (5Y)1.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.52% | ||
| ROCE | 8.9% | ||
| ROIC | 7.8% | ||
| ROICexc | 8.11% | ||
| ROICexgc | 34.04% | ||
| OM | 19.49% | ||
| PM (TTM) | 6.31% | ||
| GM | 55.59% | ||
| FCFM | 13.04% |
ROA(3y)3.65%
ROA(5y)4.54%
ROE(3y)6.23%
ROE(5y)8.33%
ROIC(3y)7.21%
ROIC(5y)7.23%
ROICexc(3y)7.52%
ROICexc(5y)7.62%
ROICexgc(3y)37.85%
ROICexgc(5y)40.71%
ROCE(3y)8.23%
ROCE(5y)8.25%
ROICexcg growth 3Y-9.53%
ROICexcg growth 5Y0.44%
ROICexc growth 3Y-3.04%
ROICexc growth 5Y1.71%
OM growth 3Y-3.43%
OM growth 5Y0.95%
PM growth 3Y-49.04%
PM growth 5Y-33.65%
GM growth 3Y0.43%
GM growth 5Y-0.56%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 4.8 | ||
| Debt/EBITDA | 2.08 | ||
| Cap/Depr | 43.09% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.37% | ||
| Profit Quality | 206.56% | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 2.72 |
F-Score5
WACC7.81%
ROIC/WACC1
Cap/Depr(3y)39.38%
Cap/Depr(5y)37.65%
Cap/Sales(3y)3.35%
Cap/Sales(5y)3.24%
Profit Quality(3y)307.01%
Profit Quality(5y)228.72%
High Growth Momentum
Growth
EPS 1Y (TTM)2.71%
EPS 3Y1.67%
EPS 5Y4.67%
EPS Q2Q%9.06%
EPS Next Y1.3%
EPS Next 2Y3.42%
EPS Next 3Y3.82%
EPS Next 5Y8.54%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.74%
Revenue growth 5Y3.26%
Sales Q2Q%2.28%
Revenue Next Year8.17%
Revenue Next 2Y9.41%
Revenue Next 3Y7.86%
Revenue Next 5Y7.72%
EBIT growth 1Y5.63%
EBIT growth 3Y-0.78%
EBIT growth 5Y4.24%
EBIT Next Year10.81%
EBIT Next 3Y9.27%
EBIT Next 5Y6.67%
FCF growth 1Y22.13%
FCF growth 3Y-4.23%
FCF growth 5Y8.62%
OCF growth 1Y25.21%
OCF growth 3Y-0.81%
OCF growth 5Y7.66%